{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T11:54:51Z","timestamp":1788263691109,"version":"build-2803163510"},"reference-count":40,"publisher":"American Society for Microbiology","issue":"8","license":[{"start":{"date-parts":[[2005,8,1]],"date-time":"2005-08-01T00:00:00Z","timestamp":1122854400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.asm.org\/non-commercial-tdm-license"}],"content-domain":{"domain":["journals.asm.org"],"crossmark-restriction":true},"short-container-title":["J Clin Microbiol"],"published-print":{"date-parts":[[2005,8]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n          <jats:p>\n            The in vitro activity of itraconazole was determined against 7,299 isolates of\n            <jats:italic>Candida<\/jats:italic>\n            spp., 1,615 isolates of\n            <jats:italic>Cryptococcus neoformans<\/jats:italic>\n            , and 445 isolates of\n            <jats:italic>Aspergillus<\/jats:italic>\n            spp. obtained from over 200 medical centers worldwide. Itraconazole was active against all\n            <jats:italic>Candida<\/jats:italic>\n            spp. (96% of MICs were \u22641 \u03bcg\/ml) with the exception of\n            <jats:italic>C. glabrata<\/jats:italic>\n            (77% of MICs were \u22641 \u03bcg\/ml). Itraconazole inhibited 94% of\n            <jats:italic>C. krusei<\/jats:italic>\n            and 84% of other fluconazole-resistant\n            <jats:italic>Candida<\/jats:italic>\n            species, exclusive of\n            <jats:italic>C. glabrata<\/jats:italic>\n            , at a MIC of \u22641 \u03bcg\/ml. Itraconazole was not active against fluconazole-resistant isolates of\n            <jats:italic>C. glabrata<\/jats:italic>\n            . Only modest activity was seen against\n            <jats:italic>C. neoformans<\/jats:italic>\n            (80% of MICs were \u22641 \u03bcg\/ml); however, itraconazole showed excellent activity against\n            <jats:italic>Aspergillus<\/jats:italic>\n            spp. (94% of MICs were \u22641 \u03bcg\/ml). These results provide an update on the antifungal activity of itraconazole against major opportunistic fungal pathogens. In light of the new intravenous formulation of itraconazole these data suggest that this agent remains a viable systemically active antifungal agent.\n          <\/jats:p>","DOI":"10.1128\/jcm.43.8.3807-3810.2005","type":"journal-article","created":{"date-parts":[[2005,8,4]],"date-time":"2005-08-04T22:25:57Z","timestamp":1123194357000},"page":"3807-3810","update-policy":"https:\/\/doi.org\/10.1128\/asmj-crossmark-policy-page","source":"Crossref","is-referenced-by-count":62,"title":["In Vitro Susceptibilities of Clinical Isolates of\n            <i>Candida<\/i>\n            Species,\n            <i>Cryptococcus neoformans<\/i>\n            , and\n            <i>Aspergillus<\/i>\n            Species to Itraconazole: Global Survey of 9,359 Isolates Tested by Clinical and Laboratory Standards Institute Broth Microdilution Methods"],"prefix":"10.1128","volume":"43","author":[{"given":"M. A.","family":"Pfaller","sequence":"first","affiliation":[{"name":"Departments of Pathology"},{"name":"Department of Epidemiology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Boyken","sequence":"additional","affiliation":[{"name":"Departments of Pathology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R. J.","family":"Hollis","sequence":"additional","affiliation":[{"name":"Departments of Pathology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S. A.","family":"Messer","sequence":"additional","affiliation":[{"name":"Departments of Pathology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Tendolkar","sequence":"additional","affiliation":[{"name":"Departments of Pathology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D. J.","family":"Diekema","sequence":"additional","affiliation":[{"name":"Departments of Pathology"},{"name":"Medicine, Roy J. and Lucille A. Carver College of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"235","reference":[{"key":"e_1_3_2_2_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.38.7.1530"},{"key":"e_1_3_2_3_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.42.7.1862"},{"key":"e_1_3_2_4_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-135-6-200109180-00010"},{"key":"e_1_3_2_5_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.45.3.981-985.2001"},{"key":"e_1_3_2_6_2","doi-asserted-by":"publisher","DOI":"10.1136\/jcp.50.6.477"},{"key":"e_1_3_2_7_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkh548"},{"key":"e_1_3_2_8_2","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.41.8.3623-3626.2003"},{"key":"e_1_3_2_9_2","doi-asserted-by":"publisher","DOI":"10.1023\/A:1010954803886"},{"key":"e_1_3_2_10_2","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.42.4.1519-1527.2004"},{"key":"e_1_3_2_11_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.44.7.1887-1893.2000"},{"key":"e_1_3_2_12_2","first-page":"1693","volume":"2","year":"2003","unstructured":"Hazen, K. C., and S. A. Howell. 2003. Candida, Cryptococcus, and other yeasts of medical importance, p. 1693-1711. In P. R. Murray, E. J. Baron, J. H. Jorgensen, M. A. Pfaller, and R. H. Yolken (ed.), Manual of Clinical Microbiology, 8th ed., vol. 2. American Society for Microbiology, Washington, D.C.","journal-title":"Manual of Clinical Microbiology"},{"key":"e_1_3_2_13_2","doi-asserted-by":"publisher","DOI":"10.1517\/13543784.9.3.593"},{"key":"e_1_3_2_14_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.49.2.512-517.2005"},{"key":"e_1_3_2_15_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1201-9712(03)90003-8"},{"key":"e_1_3_2_16_2","doi-asserted-by":"publisher","DOI":"10.1086\/315193"},{"key":"e_1_3_2_17_2","first-page":"1527","volume":"103","year":"2004","unstructured":"Marr, K. A., F. Crippa, W. Leisenring, M. Hoyle, M. Boeckh, S. A. Balajee, W. G. Nichols, B. Musher, and L. Corey. 2004. Itraconazole versus fluconazole for prevention of fungal infections in patients receiving allogeneic stem cell transplants. Transplantation103:1527-1533.","journal-title":"Transplantation"},{"key":"e_1_3_2_18_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.39.7.1512"},{"key":"e_1_3_2_19_2","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.11930"},{"key":"e_1_3_2_20_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.48.8.3151-3153.2004"},{"key":"e_1_3_2_21_2","unstructured":"National Committee for Clinical Laboratory Standards. 2002. Reference method for broth dilution antifungal susceptibility testing of yeasts. Approved standard M27-A2. National Committee for Clinical Laboratory Standards Wayne Pa."},{"key":"e_1_3_2_22_2","unstructured":"National Committee for Clinical Laboratory Standards. 2002. Reference method for broth dilution antifungal susceptibility testing of filamentous fungi. Approved standard M38-A. National Committee for Clinical Laboratory Standards Wayne Pa."},{"key":"e_1_3_2_23_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.47.10.3149-3154.2003"},{"key":"e_1_3_2_24_2","doi-asserted-by":"publisher","DOI":"10.1086\/380796"},{"key":"e_1_3_2_25_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.46.6.1723-1727.2002"},{"key":"e_1_3_2_26_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.47.3.1068-1071.2003"},{"key":"e_1_3_2_27_2","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.42.10.4419-4431.2004"},{"key":"e_1_3_2_28_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1470-9465.2004.t01-1-00844.x"},{"key":"e_1_3_2_29_2","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.43.5.2163-2167.2005"},{"key":"e_1_3_2_30_2","first-page":"192","volume":"14","year":"2004","unstructured":"Pierard, G.-E., M. Kharfi, M.-D. Salomon-Neiera, M.-R. Kamoun, and C. Pierard-Franchimont. 2004. Itraconazole in human aspergillosis revisited. J. Mycol. Med.14:192-200.","journal-title":"J. Mycol. Med."},{"key":"e_1_3_2_31_2","doi-asserted-by":"publisher","DOI":"10.1093\/clinids\/24.2.235"},{"key":"e_1_3_2_32_2","doi-asserted-by":"publisher","DOI":"10.1086\/313757"},{"key":"e_1_3_2_33_2","doi-asserted-by":"publisher","DOI":"10.1345\/aph.19237"},{"key":"e_1_3_2_34_2","doi-asserted-by":"publisher","DOI":"10.1128\/CMR.12.1.40"},{"key":"e_1_3_2_35_2","first-page":"1726","volume":"2","year":"2003","unstructured":"Sigler, L., and P. E. Verweij. 2003. Aspergillus, Fusarium, and other opportunistic moniliaceous fungi, p. 1726-1760. In P. R. Murray, E. J. Baron, J. H. Jorgensen, M. A. Pfaller, and R. H. Yolken (ed.), Manual of clinical microbiology, 8th ed., vol. 2. American Society for Microbiology, Washington, D.C.","journal-title":"Manual of clinical microbiology"},{"key":"e_1_3_2_36_2","doi-asserted-by":"publisher","DOI":"10.1086\/313756"},{"key":"e_1_3_2_37_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.41.12.2714"},{"key":"e_1_3_2_38_2","first-page":"361","volume":"1","year":"1999","unstructured":"Verweij, P. E., B. E. de Pauw, and J. F. Meis. 1999. Voriconazole. Curr. Opin. Anti-Infect. Investig. Drugs1:361-372.","journal-title":"Curr. Opin. Anti-Infect. Investig. Drugs"},{"key":"e_1_3_2_39_2","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.40.7.2648-2650.2002"},{"key":"e_1_3_2_40_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2710.2001.00338.x"},{"key":"e_1_3_2_41_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-138-9-200305060-00006"}],"container-title":["Journal of Clinical Microbiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/JCM.43.8.3807-3810.2005","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/JCM.43.8.3807-3810.2005","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,5]],"date-time":"2022-03-05T04:43:49Z","timestamp":1646455429000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.asm.org\/doi\/10.1128\/JCM.43.8.3807-3810.2005"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,8]]},"references-count":40,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2005,8]]}},"alternative-id":["10.1128\/JCM.43.8.3807-3810.2005"],"URL":"https:\/\/doi.org\/10.1128\/jcm.43.8.3807-3810.2005","relation":{},"ISSN":["0095-1137","1098-660X"],"issn-type":[{"value":"0095-1137","type":"print"},{"value":"1098-660X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,8]]},"assertion":[{"value":"2005-03-30","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2005-05-17","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2005-08-01","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}